InVivium Alto
Startup rounds since 2014 with a InVivium Alto investor on the board, and the firm's own fund filings.
Raises
17
since 2014
Unannounced
0
no announcement found, of those filed since 2025
Funds
1
fund filings under the firm's name
Rounds
- Alto Neuroscience, Inc.$45M
- Alto Neuroscience, Inc.$59.3M
- Alto Neuroscience, Inc.$31.9M
- Alto Neuroscience, Inc.$7.72M
- Neochord Inc$1.75M
- Neochord Inc$1M
- Neochord Inc$2.8M
- JumpCode Genomics, Inc.$21M
- Greenlight Biosciences Inc.$103M
- Oncology Analytics, Inc.$25M
- Apervita, Inc.$22.6M
- AIC Innovations Group, Inc.$16.8M
- Apervita, Inc.Undisclosed
- AIC Innovations Group, Inc.$11.9M
- Integrated Diagnostics, Inc.$6.1M
- Amphora Medical, Inc.$12.8M
- Integrated Diagnostics, Inc.$31.7M
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2023 | 4 | — |
| 2022 | 1 | — |
| 2021 | 2 | — |
| 2020 | 3 | — |
| 2019 | 2 | — |
| 2017 | 2 | — |
| 2016 | 1 | — |
| 2015 | 1 | — |
| 2014 | 1 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| InVivium Alto SPV, LLC | 13 Nov 2023 | Open-ended | — |
Listed because a InVivium Alto fund's filing names a director of each company. A name match is not a verified identity.